4K7T
Structure of the ternary complex of bacitracin, zinc, and geranyl-pyrophosphate
Summary for 4K7T
| Entry DOI | 10.2210/pdb4k7t/pdb |
| Related PRD ID | PRD_001070 |
| Descriptor | bacitracin A2, GERANYL DIPHOSPHATE, ZINC ION, ... (5 entities in total) |
| Functional Keywords | antibiotic, bacitracin, cell-wall biosynthesis inhibitor, undecaprenyl-pyrophosphate |
| Biological source | Bacillus subtilis |
| Total number of polymer chains | 1 |
| Total formula weight | 1863.35 |
| Authors | Economou, N.J.,Loll, P.J. (deposition date: 2013-04-17, release date: 2013-08-14, Last modification date: 2024-10-16) |
| Primary citation | Economou, N.J.,Cocklin, S.,Loll, P.J. High-resolution crystal structure reveals molecular details of target recognition by bacitracin. Proc.Natl.Acad.Sci.USA, 110:14207-14212, 2013 Cited by PubMed Abstract: Bacitracin is a metalloantibiotic agent that is widely used as a medicine and feed additive. It interferes with bacterial cell-wall biosynthesis by binding undecaprenyl-pyrophosphate, a lipid carrier that serves as a critical intermediate in cell wall production. Despite bacitracin's broad use, the molecular details of its target recognition have not been elucidated. Here we report a crystal structure for the ternary complex of bacitracin A, zinc, and a geranyl-pyrophosphate ligand at a resolution of 1.1 Å. The antibiotic forms a compact structure that completely envelopes the ligand's pyrophosphate group, together with flanking zinc and sodium ions. The complex adopts a highly amphipathic conformation that offers clues to antibiotic function in the context of bacterial membranes. Bacitracin's efficient sequestration of its target represents a previously unseen mode for the recognition of lipid pyrophosphates, and suggests new directions for the design of next-generation antimicrobial agents. PubMed: 23940351DOI: 10.1073/pnas.1308268110 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.1 Å) |
Structure validation
Download full validation report






